These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3538633)

  • 1. Biological response modifiers in the management of viral infection.
    Ford RB
    Vet Clin North Am Small Anim Pract; 1986 Nov; 16(6):1191-204. PubMed ID: 3538633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tests on protection against viral diseases.
    Büttner M; Mayr A
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):205-15. PubMed ID: 2431829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with BRMs in cancer and infectious diseases.
    Garaci E; Pica F; Rasi G; Palamara AT; Favalli C
    Mech Ageing Dev; 1997 Jun; 96(1-3):103-16. PubMed ID: 9223114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic response modifiers as antivirals in immunosuppressed hosts.
    Morahan PS; Pinto AJ
    Adv Exp Med Biol; 1992; 319():243-51. PubMed ID: 1384281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NCI preclinical screen of biological response modifiers.
    Talmadge JE; Fidler IJ; Oldham RK
    Behring Inst Mitt; 1984 May; (74):189-94. PubMed ID: 6206841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of BRM in skin cancer].
    Ishihara K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1603-8. PubMed ID: 3382232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy in virus diseases].
    Schulte-Wissermann H; Schofer O
    Monatsschr Kinderheilkd; 1986 Apr; 134(4):172-81. PubMed ID: 2422548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons as therapeutic agents for infectious diseases.
    Bergman SJ; Ferguson MC; Santanello C
    Infect Dis Clin North Am; 2011 Dec; 25(4):819-34. PubMed ID: 22054758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulators as antiviral agents.
    Steele RW; Charlton RK
    Clin Lab Med; 1987 Dec; 7(4):911-24. PubMed ID: 2446821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacology of the immunotherapy of cancer, infection, and autoimmunity.
    Hadden JW
    Fundam Clin Pharmacol; 1987; 1(4):283-96. PubMed ID: 3436614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and vaccine adjuvants as biological response modifiers.
    Speil C; Rzepka R
    Infect Dis Clin North Am; 2011 Dec; 25(4):755-72. PubMed ID: 22054754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children.
    Davies HD;
    Pediatrics; 2016 Aug; 138(2):. PubMed ID: 27432853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for designing synthetic immune agonists.
    Wu TY
    Immunology; 2016 Aug; 148(4):315-25. PubMed ID: 27213842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 15. The neonatal immune system: immunomodulation of infections in early life.
    Futata EA; Fusaro AE; de Brito CA; Sato MN
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):289-98. PubMed ID: 22397563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo and in vivo characterization of biological response modifiers (BRMs).
    Masihi KN; Talmadge JE
    Dev Biol Stand; 1992; 77():143-5. PubMed ID: 1426655
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulating agents and hepatic drug-metabolizing enzymes.
    Descotes J
    Drug Metab Rev; 1985; 16(1-2):175-84. PubMed ID: 3905318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-viral immunodeficiencies in man.
    Hobbs JR
    Clin Ter; 1992 Feb; 140(2):115-21. PubMed ID: 1568355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Sjogren MH
    J Gastroenterol Hepatol; 2004 Dec; 19(12):S69-72. PubMed ID: 15641207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioterrorism and emerging infectious disease - antimicrobials, therapeutics and immune-modulators. Viral infections.
    de la Torre JC
    IDrugs; 2004 Feb; 7(2):96-9. PubMed ID: 15057646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.